$CWBC
Community West Bancshares Stock $cwbc

$cwbc Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000112737120000157 Filed on November 04, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue		$16.43M	$16.93M
YoY Change		-2.93%	3.91%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.500M	$1.410M	$1.370M
YoY Change	12.78%	2.92%	-18.93%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense		$388.0K	$722.0K
YoY Change		-46.26%	88.51%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$9.240M	$5.786M	$8.143M
YoY Change	49.76%	-28.95%	7.44%
Income Tax	$2.160M	$1.442M	$2.452M
% Of Pretax Income	23.38%	24.92%	30.11%
Net Earnings	$7.080M	$4.344M	$5.691M
YoY Change	59.1%	-23.67%	-1.06%
Net Earnings / Revenue		26.44%	33.62%
Basic Earnings Per Share		$0.35	$0.43
Diluted Earnings Per Share	$565.5K	$0.35	$0.42
COMMON SHARES
Basic Shares Outstanding	12.51M shares	12.47M shares	13.36M shares
Diluted Shares Outstanding		12.50M shares	13.45M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$70.28M	$87.01M	$43.04M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$8.228M	$7.257M	$7.804M
YoY Change	8.01%	-7.01%	-12.01%
Goodwill	$53.78M		$53.78M
YoY Change	0.0%		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.004B	$1.951B	$1.584B
YoY Change	25.51%	23.13%	4.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$31.20M	$28.40M	$31.00M
YoY Change	3.31%	-8.39%	22.53%
Accrued Expenses	$6.000M	$6.200M	$6.800M
YoY Change	-4.76%	-8.82%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$31.20M	$28.40M	$31.00M
YoY Change	3.31%	-8.39%	22.53%
LONG-TERM LIABILITIES
Long-Term Debt	$5.200M	$5.200M	$5.200M
YoY Change	0.0%	0.0%	0.0%
Other Long-Term Liabilities	$9.200M	$9.900M	$10.20M
YoY Change	-5.15%	-2.94%	10.87%
Total Long-Term Liabilities	$5.200M	$5.200M	$5.200M
YoY Change	0.0%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.20M	$28.40M	$31.00M
Total Long-Term Liabilities	$5.200M	$5.200M	$5.200M
Total Liabilities	$1.759B	$1.715B	$1.351B
YoY Change	28.53%	26.93%	3.44%
SHAREHOLDERS EQUITY
Retained Earnings	$150.7M	$145.0M	$132.9M
YoY Change	10.9%	9.11%	14.35%
Common Stock	$79.42M	$79.27M	$94.52M
YoY Change	-11.15%	-16.13%	-9.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$245.0M	$235.8M	$233.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.004B	$1.951B	$1.584B
YoY Change	25.51%	23.13%	4.26%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	$7.080M	$4.344M	$5.691M
YoY Change	59.1%	-23.67%	-1.06%
Depreciation, Depletion And Amortization	$1.500M	$1.410M	$1.370M
YoY Change	12.78%	2.92%	-18.93%
Cash From Operating Activities	$10.17M	$5.050M	$7.040M
YoY Change	103.4%	-28.27%	337.27%
INVESTING ACTIVITIES
Capital Expenditures	-$1.180M	-$210.0K	-$430.0K
YoY Change	686.67%	-51.16%	290.91%
Acquisitions
YoY Change
Other Investing Activities	-$65.88M	-$66.77M	$26.47M
YoY Change	822.69%	-352.25%	-66.42%
Cash From Investing Activities	-$67.06M	-$66.98M	$26.04M
YoY Change	819.89%	-357.22%	-66.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	40.16M	30.38M	-38.65M
YoY Change	239.48%	-178.6%	-51.48%
NET CHANGE
Cash From Operating Activities	10.17M	5.050M	7.040M
Cash From Investing Activities	-67.06M	-66.98M	26.04M
Cash From Financing Activities	40.16M	30.38M	-38.65M
Net Change In Cash	-16.73M	-31.55M	-5.570M
YoY Change	-275.37%	466.43%	-931.34%
FREE CASH FLOW
Cash From Operating Activities	$10.17M	$5.050M	$7.040M
Capital Expenditures	-$1.180M	-$210.0K	-$430.0K
Free Cash Flow	$11.35M	$5.260M	$7.470M
YoY Change	120.39%	-29.59%	334.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001127371
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	14657000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9130000	USD
CY2020Q3	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2019Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12507658	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13052407	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12507658	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13052407	shares
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q3	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2019Q3	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-31977
	dei	Entity Registrant Name EntityRegistrantName	CENTRAL VALLEY COMMUNITY BANCORP
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0539125
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7100 N. Financial Dr., Suite 101
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fresno
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93720
	dei	City Area Code CityAreaCode	559
	dei	Local Phone Number LocalPhoneNumber	298-1775
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	CVCY
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12507611	shares
CY2020Q3	us-gaap	Cash And Due From Banks CashAndDueFromBanks	33447000	USD
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	24195000	USD
CY2020Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	53563000	USD
CY2019Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	28379000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87010000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52574000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	631854000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	470746000	USD
CY2020Q3	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7655000	USD
CY2019Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7472000	USD
CY2020Q3	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1095232000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	934250000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7257000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7618000	USD
CY2020Q3	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	29769000	USD
CY2019Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	30230000	USD
CY2020Q3	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	5595000	USD
CY2019Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	6062000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	53777000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	53777000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1356000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1878000	USD
CY2020Q3	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	31055000	USD
CY2019Q4	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	32148000	USD
CY2020Q3	us-gaap	Assets Assets	1950560000	USD
CY2019Q4	us-gaap	Assets Assets	1596755000	USD
CY2020Q3	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	804893000	USD
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	594627000	USD
CY2020Q3	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	876321000	USD
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	738658000	USD
CY2020Q3	us-gaap	Deposits Deposits	1681214000	USD
CY2019Q4	us-gaap	Deposits Deposits	1333285000	USD
CY2020Q3	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2019Q4	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2020Q3	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	28411000	USD
CY2019Q4	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	30187000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	1714780000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1368627000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	145045000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	135932000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	11466000	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	79269000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	89379000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2817000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	235780000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	228128000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1950560000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1596755000	USD
CY2020Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13190000	USD
CY2019Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13238000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	38688000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	38747000	USD
CY2020Q3	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	26000	USD
CY2019Q3	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	74000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	222000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	283000	USD
CY2020Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2771000	USD
CY2019Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	3462000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	8996000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	9821000	USD
CY2020Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	444000	USD
CY2019Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	153000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1015000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1144000	USD
CY2020Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16431000	USD
CY2019Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16927000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	48921000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	49995000	USD
CY2020Q3	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	363000	USD
CY2019Q3	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	566000	USD
	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	1169000	USD
	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	1428000	USD
CY2020Q3	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	25000	USD
CY2019Q3	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	51000	USD
	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	106000	USD
	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	163000	USD
CY2020Q3	us-gaap	Interest Expense Other InterestExpenseOther	0	USD
CY2019Q3	us-gaap	Interest Expense Other InterestExpenseOther	105000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	0	USD
	us-gaap	Interest Expense Other InterestExpenseOther	419000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	388000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	722000	USD
	us-gaap	Interest Expense InterestExpense	1275000	USD
	us-gaap	Interest Expense InterestExpense	2010000	USD
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16043000	USD
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16205000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	47646000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	47985000	USD
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	600000	USD
CY2019Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	250000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4975000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	525000	USD
CY2020Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	15443000	USD
CY2019Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	15955000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	42671000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	47460000	USD
CY2020Q3	cvcy	Service Charges ServiceCharges	463000	USD
CY2019Q3	cvcy	Service Charges ServiceCharges	672000	USD
	cvcy	Service Charges ServiceCharges	1556000	USD
	cvcy	Service Charges ServiceCharges	2075000	USD
CY2020Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	178000	USD
CY2019Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	184000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	536000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	545000	USD
CY2020Q3	cvcy	Interchange Fees InterchangeFees	355000	USD
CY2019Q3	cvcy	Interchange Fees InterchangeFees	374000	USD
	cvcy	Interchange Fees InterchangeFees	995000	USD
	cvcy	Interchange Fees InterchangeFees	1101000	USD
CY2020Q3	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	57000	USD
CY2019Q3	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	1685000	USD
	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	4197000	USD
	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	5196000	USD
CY2020Q3	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	71000	USD
CY2019Q3	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	109000	USD
	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	253000	USD
	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	348000	USD
CY2020Q3	cvcy	Loan Placement Fees LoanPlacementFees	685000	USD
CY2019Q3	cvcy	Loan Placement Fees LoanPlacementFees	288000	USD
	cvcy	Loan Placement Fees LoanPlacementFees	1545000	USD
	cvcy	Loan Placement Fees LoanPlacementFees	647000	USD
CY2020Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	262000	USD
CY2019Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	410000	USD
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1577000	USD
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1384000	USD
CY2020Q3	us-gaap	Noninterest Income NoninterestIncome	2071000	USD
CY2019Q3	us-gaap	Noninterest Income NoninterestIncome	3722000	USD
	us-gaap	Noninterest Income NoninterestIncome	10659000	USD
	us-gaap	Noninterest Income NoninterestIncome	11296000	USD
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6729000	USD
CY2019Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6731000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	21053000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	20133000	USD
CY2020Q3	us-gaap	Occupancy Net OccupancyNet	1196000	USD
CY2019Q3	us-gaap	Occupancy Net OccupancyNet	1317000	USD
	us-gaap	Occupancy Net OccupancyNet	3479000	USD
	us-gaap	Occupancy Net OccupancyNet	4248000	USD
CY2020Q3	us-gaap	Professional Fees ProfessionalFees	715000	USD
CY2019Q3	us-gaap	Professional Fees ProfessionalFees	404000	USD
	us-gaap	Professional Fees ProfessionalFees	1695000	USD
	us-gaap	Professional Fees ProfessionalFees	1011000	USD
CY2020Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	594000	USD
CY2019Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	390000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1484000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1186000	USD
CY2020Q3	cvcy	Regulatory Assessments RegulatoryAssessments	147000	USD
CY2019Q3	cvcy	Regulatory Assessments RegulatoryAssessments	-69000	USD
	cvcy	Regulatory Assessments RegulatoryAssessments	340000	USD
	cvcy	Regulatory Assessments RegulatoryAssessments	217000	USD
CY2020Q3	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	144000	USD
CY2019Q3	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	270000	USD
	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	625000	USD
	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	647000	USD
CY2020Q3	cvcy	Information Technology InformationTechnology	594000	USD
CY2019Q3	cvcy	Information Technology InformationTechnology	614000	USD
	cvcy	Information Technology InformationTechnology	1804000	USD
	cvcy	Information Technology InformationTechnology	1996000	USD
CY2020Q3	cvcy	Directors Expenses DirectorsExpenses	140000	USD
CY2019Q3	cvcy	Directors Expenses DirectorsExpenses	184000	USD
	cvcy	Directors Expenses DirectorsExpenses	468000	USD
	cvcy	Directors Expenses DirectorsExpenses	552000	USD
CY2020Q3	us-gaap	Advertising Expense AdvertisingExpense	167000	USD
CY2019Q3	us-gaap	Advertising Expense AdvertisingExpense	190000	USD
	us-gaap	Advertising Expense AdvertisingExpense	507000	USD
	us-gaap	Advertising Expense AdvertisingExpense	590000	USD
CY2020Q3	cvcy	Internet Banking Expense InternetBankingExpense	167000	USD
CY2019Q3	cvcy	Internet Banking Expense InternetBankingExpense	215000	USD
	cvcy	Internet Banking Expense InternetBankingExpense	545000	USD
	cvcy	Internet Banking Expense InternetBankingExpense	608000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	521000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	521000	USD
CY2020Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	961000	USD
CY2019Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1114000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2784000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	3263000	USD
CY2020Q3	us-gaap	Noninterest Expense NoninterestExpense	11728000	USD
CY2019Q3	us-gaap	Noninterest Expense NoninterestExpense	11534000	USD
	us-gaap	Noninterest Expense NoninterestExpense	35305000	USD
	us-gaap	Noninterest Expense NoninterestExpense	34972000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5786000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8143000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18025000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23784000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1442000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2452000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4757000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6790000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4344000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5691000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13268000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16994000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12471070	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13360030	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12551480	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13515109	shares
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12496174	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13450187	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12596172	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13615552	shares
CY2020Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
CY2019Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.33
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.32
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	4344000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	5691000	USD
	us-gaap	Net Income Loss NetIncomeLoss	13268000	USD
	us-gaap	Net Income Loss NetIncomeLoss	16994000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	5798000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	3081000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	16477000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	19589000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	57000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	1685000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	4197000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	5196000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	5741000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	1396000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	12280000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	14393000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1698000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	412000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	3631000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	4255000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4043000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	984000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8649000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	10138000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8387000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6675000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21917000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27132000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	231680000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	5691000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	984000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	41000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	136000	USD
CY2019Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1479000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
CY2019Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	3873000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	233182000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	228558000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	4344000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4043000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	47000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113000	USD
CY2020Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1375000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4353000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	10199000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	235780000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	219738000	USD
	us-gaap	Net Income Loss NetIncomeLoss	16994000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	10138000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	171000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	100000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	430000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	163000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	233182000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	228128000	USD
	us-gaap	Net Income Loss NetIncomeLoss	13268000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	8649000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	162000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	141000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	362000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4155000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	277000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11052000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	235780000	USD
	us-gaap	Net Income Loss NetIncomeLoss	13268000	USD
	us-gaap	Net Income Loss NetIncomeLoss	16994000	USD
	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	5304000	USD
	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	16000	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	668000	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	1410000	USD
	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	994000	USD
	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	620000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3328000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3556000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	362000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	430000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4975000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	525000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	4197000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	5196000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	6000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	183000	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	253000	USD
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	376000	USD
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	545000	USD
	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	462000	USD
	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	0	USD
	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	1394000	USD
	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	8720000	USD
	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	-1636000	USD
	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	10500000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1227000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1345000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6822000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16720000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	319707000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	286896000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	147811000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	280991000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	25536000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	17140000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	160653000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	23925000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	307000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	730000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	250000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	1000000	USD
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-467000	USD
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-780000	USD
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	1550000	USD
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-305547000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13640000	USD
	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	353622000	USD
	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	27003000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-5693000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	445000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	0	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	505500000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	0	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	510500000	USD
	us-gaap	Proceeds From Deposits With Other Institutions ProceedsFromDepositsWithOtherInstitutions	0	USD
	us-gaap	Proceeds From Deposits With Other Institutions ProceedsFromDepositsWithOtherInstitutions	2870000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2870000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11052000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10199000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	162000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	171000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	277000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	163000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4155000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4353000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	333161000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8230000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34436000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11310000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52574000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31727000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87010000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43037000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1354000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1957000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5120000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6580000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1678000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1643000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10129000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	No customer accounts for more than 10 percent of revenues for the Company or the Bank.
CY2020Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	20345000	USD
CY2020Q3	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	157758000	USD
CY2020Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	16279000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	3999000	USD
CY2020Q3	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	4813000	USD
CY2019Q4	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	1182000	USD
CY2020Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	615575000	USD
CY2020Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4066000	USD
CY2020Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	631854000	USD
CY2019Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	466747000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	8688000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4689000	USD
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	470746000	USD
CY2020Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	25442000	USD
CY2019Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	77375000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	147811000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	280991000	USD
CY2020Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1035000	USD
CY2019Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1709000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	5539000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	5316000	USD
CY2020Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	978000	USD
CY2019Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	24000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1342000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	120000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	1241000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	1536000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	17000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	498000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	132152000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1381000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	94150000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2685000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	226302000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	4066000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	159032000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2476000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	88855000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2213000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	247887000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	4689000	USD
	cvcy	Threshold Period Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPeriodOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	P12M
	cvcy	Threshold Percentage Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPercentageOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	0.10
	cvcy	Threshold Amount Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdAmountOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	10000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2020Q3	cvcy	Available For Sale Securities Number Of Securities Loss Position AvailableForSaleSecuritiesNumberOfSecuritiesLossPosition	2	Loans
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	295000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	304000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1314000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1454000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	31221000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	34368000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	247676000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	258747000	USD
CY2020Q3	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateAmortizedCostBasis	280506000	USD
CY2020Q3	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateFairValue	294873000	USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	615575000	USD
CY2020Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	631854000	USD
CY2020Q3	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	-3789000	USD
CY2019Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	1515000	USD
CY2020Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1109889000	USD
CY2020Q3	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	943380000	USD
CY2019Q4	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2020Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	14657000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9130000	USD
CY2020Q3	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1095232000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	934250000	USD
CY2020Q3	cvcy	Loansand Leases Receivable Allowance Numberof Components LoansandLeasesReceivableAllowanceNumberofComponents	2	component
CY2020Q3	cvcy	Financing Receivable Allowance For Credit Losses Methodology Change Number Of Rolling Quarters Used In Analysis FinancingReceivableAllowanceForCreditLossesMethodologyChangeNumberOfRollingQuartersUsedInAnalysis	47	quarter
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13937000	USD
CY2020Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	600000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	45000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	165000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14657000	USD
CY2019Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9405000	USD
CY2019Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	250000	USD
CY2019Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	215000	USD
CY2019Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	55000	USD
CY2019Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9495000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9130000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	4975000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	169000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	721000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14657000	USD
CY2018Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9104000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	525000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	280000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	146000	USD
CY2019Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9495000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14657000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	739000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	13918000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9130000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	40000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	9090000	USD
CY2020Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	1113678000	USD
CY2020Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	12686000	USD
CY2020Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1100992000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	941865000	USD
CY2019Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	3734000	USD
CY2019Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	938131000	USD
CY2020Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	1113678000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	941865000	USD
CY2020Q3	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	256000	USD
CY2020Q3	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1113422000	USD
CY2020Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	1113678000	USD
CY2020Q3	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	3458000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	784000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	941081000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	941865000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	1693000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	8236000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	8341000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	4450000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	4484000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	739000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	12686000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	12825000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	739000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	2230000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	2796000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	1504000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	1509000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	40000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	3734000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	4305000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	40000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	5536000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	3000	USD
CY2019Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	3864000	USD
CY2019Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	13000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	8066000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	167000	USD
CY2019Q3	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	1373000	USD
CY2019Q3	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	18000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	13602000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	170000	USD
CY2019Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	5237000	USD
CY2019Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	31000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	3486000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	9000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	3940000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	86000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	7818000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	569000	USD
CY2020Q3	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	33000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	1604000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	53000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	11304000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	578000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	5544000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	139000	USD
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	135000	USD
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	105000	USD
CY2020Q3	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	82000	USD
CY2019Q3	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	39000	USD
CY2020Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	9228000	USD
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	2362000	USD
CY2019Q4	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	38000	USD
CY2020Q3	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0	USD
	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2020Q4	us-gaap	Goodwill Goodwill	53777000	USD
CY2020Q3	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2019Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2020Q3	us-gaap	Other Commitment OtherCommitment	2475000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4344000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5691000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13268000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16994000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12471070	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13360030	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12551480	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13515109	shares
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4344000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5691000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13268000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16994000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12471070	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13360030	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12551480	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13515109	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	25104	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	90157	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	44692	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	100443	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12496174	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	362000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	430000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13450187	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12596172	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13615552	shares
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2020Q3	cvcy	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans	4	plan
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	121120	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.73
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	43300	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.38
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	550	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.40
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	77270	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M7D
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	182699000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	77270	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y9M7D
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	182699000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	77270	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	10.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P1Y9M7D
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	182699000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	51000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	432000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	269000	USD
CY2020Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	50000	USD
CY2019Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	277000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	163000	USD
CY2020Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	6000	USD
CY2019Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	78000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	25000	USD
CY2020Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	600000	USD
CY2019Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	250000	USD
CY2020Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13190000	USD
CY2019Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13238000	USD
CY2020Q3	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	363000	USD
CY2019Q3	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	566000	USD
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	600000	USD
CY2019Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	250000	USD
CY2020Q3	cvcy	Service Charges ServiceCharges	463000	USD
CY2019Q3	cvcy	Service Charges ServiceCharges	672000	USD
CY2020Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	262000	USD
CY2019Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	410000	USD
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6729000	USD
CY2019Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6731000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1442000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2452000	USD

Files In Submission

Name	View Source	Status
0001127371-20-000157-index-headers.html	Edgar Link	pending
0001127371-20-000157-index.html	Edgar Link	pending
0001127371-20-000157.txt	Edgar Link	pending
0001127371-20-000157-xbrl.zip	Edgar Link	pending
cvcy-20200930.htm	Edgar Link	pending
cvcy-20200930.xsd	Edgar Link	pending
cvcy-20200930_cal.xml	Edgar Link	unprocessable
cvcy-20200930_def.xml	Edgar Link	unprocessable
cvcy-20200930_htm.xml	Edgar Link	completed
cvcy-20200930_lab.xml	Edgar Link	unprocessable
cvcy-20200930_pre.xml	Edgar Link	unprocessable
exhibit3112020q3-ng.htm	Edgar Link	pending
exhibit3122020q3-ng.htm	Edgar Link	pending
exhibit3212020q3-ng.htm	Edgar Link	pending
exhibit3222020q3-ng.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBC
Community West Bancshares Stock $cwbc

2020 Q4 Form 10-Q Financial Statement

#000112737120000157 Filed on November 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC Community West Bancshares Stock $cwbc

2020 Q4 Form 10-Q Financial Statement

#000112737120000157 Filed on November 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC
Community West Bancshares Stock $cwbc